Zein-alpha PZ19.1 Antibody
Product Specs
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Target Background
UniGene: Zm.102794
Q&A
Basic Research Questions
How do researchers validate the specificity of Zein-alpha PZ19.1 antibodies in plant protein studies?
Validation typically involves immunoblotting against recombinant Zein-alpha PZ19.1 protein and comparative assays with maize wild-type vs. zein-knockout mutants . For example:
-
Recombinant Zein-alpha PZ19.1 (UniProt P04705) expressed in mammalian cells serves as a positive control .
-
Negative controls include protein extracts from Zea mays lines with CRISPR-mediated zein-alpha gene deletions .
Key validation metrics:
| Parameter | Result (Source) |
|---|---|
| Molecular Weight | 19 kDa (SDS-PAGE) |
| Cross-reactivity | None with β- or γ-zein isoforms |
| Immunogen | Recombinant PZ19.1 (aa 22-186) |
What experimental conditions optimize Western blot detection of Zein-alpha PZ19.1?
Optimal conditions derive from buffer composition and protein extraction protocols:
-
Extraction: Use 70% ethanol + 0.5% β-mercaptoethanol to solubilize zeins .
-
Blocking: 5% non-fat milk in TBST reduces non-specific binding due to hydrophobic zein properties .
-
Antibody dilution: 1:1,000 in PBS-Tween 20 (0.05%) with 1% BSA improves signal-to-noise ratios.
Critical variables:
-
Zeins form aggregates >44 kDa in non-reducing conditions . Always include fresh DTT (10 mM) in loading buffers.
-
False negatives occur if methanol concentrations exceed 50% during transfer .
How does storage affect Zein-alpha PZ19.1 antibody stability?
Long-term stability requires -80°C storage in 50% glycerol, with aliquots to avoid freeze-thaw cycles . Accelerated stability studies show:
Note: 0.03% ProClin 300 preservative prevents microbial growth without affecting epitope recognition .
Advanced Research Questions
How to resolve discrepancies in Zein-alpha PZ19.1 quantification between ELISA and mass spectrometry?
Discrepancies often stem from epitope accessibility vs. total protein content:
-
ELISA: Detects immunoreactive zeins but misses truncated isoforms lacking the PZ19.1 epitope .
-
LC-MS/MS: Quantifies all zeins but requires tryptic digestion, which may underrepresent hydrophobic domains .
Case study: In Zea mays line K55, truncated 23.8 kDa α-zein (K55PC7) shows 89% sequence homology to PZ19.1 but escapes antibody detection due to C-terminal truncation .
Can Zein-alpha PZ19.1 antibodies differentiate phosphorylation states in transgenic maize models?
No—PZ19.1 targets non-phosphorylated regions (aa 50-120). For phospho-specific analysis:
-
Probe precipitates with pan-phosphoserine antibodies (e.g., Abcam ab9332) .
-
Validate via MALDI-TOF/TOF with TiO₂ phosphopeptide enrichment .
Limitation: Phosphorylation at S78 (predicted by PhosPhAt 4.0) reduces PZ19.1 binding affinity by 40% .
What strategies improve Zein-alpha PZ19.1 nanoparticle conjugation efficiency for drug delivery?
Antisolvent co-precipitation with lactoferrin (LF) enhances encapsulation:
-
Parameter Value Zein:LF ratio 1:1 (w/w) pH 5.5 (maximizes charge) Stirring time 1 hr at 30 rpm
Performance metrics:
How to address non-specific binding in immunohistochemistry using Zein-alpha PZ19.1 antibodies?
Pre-absorption controls and tissue pretreatment are critical:
-
Pre-absorb antibodies with E. coli lysate to eliminate anti-bacterial IgGs.
-
Treat maize kernel sections with 0.1% Sudan Black B to quench autofluorescence .
-
Use antigen retrieval in 10 mM citrate buffer (pH 6.0) at 95°C for 15 min .
Validation: Compare signals in wild-type vs. opaque2 mutants (zein-deficient) .
What computational tools predict Zein-alpha PZ19.1 interactions with small molecules?
Molecular docking (AutoDock Vina) and MD simulations (GROMACS) are standard:
-
PDB template: Homology model based on 19 kDa α-zein (ModBase ID: P04705) .
-
Key binding residues: L65, Q89, and V112 form hydrophobic pockets for ligand docking .
Case application: Virtual screening identified curcumin as a zein-binding compound (ΔG = -8.2 kcal/mol) .
